Importantly, a recent retrospective study had found that GLP-1 RAs reduced suicidal ideation in large cohorts of overweight or T2D patients compared to non-GLP-1R agonist anti-obesity or anti-diabetes medications [49]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.